Applied uv receives initial purchase orders in excess of $850,000 from 3sixty biopharmaceuticals, its exclusive distributor for airocide(r) air purification systems for the continent of africa

Initial order is part of $3.5 million minimum first year purchase commitment of airocide® systems mount vernon, ny / accesswire / june 18, 2021 / applied uv, inc. (nasdaq:auvi) ("applied uv" or the "company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("uvc") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that it has received orders in excess of $850,000 for its airocide® consumer and commercial air purification systems from 3sixty biopharmaceuticals (pty) ltd. ("3sixty"), the company's exclusive distributor within the continent of africa.
AUVI Ratings Summary
AUVI Quant Ranking